Xoma Royalty And Takeda Execute Strategic Royalty Sharing Transaction And Amend Existing Agreement For Mezagitamab

Dec 30 (Reuters) - Xoma Royalty Corp XOMA.O:

• XOMA ROYALTY AND TAKEDA EXECUTE STRATEGIC ROYALTY SHARING TRANSACTION AND AMEND EXISTING AGREEMENT FOR MEZAGITAMAB

• XOMA ROYALTY CORP - TAKEDA REGAINS MAJORITY ROYALTY INTEREST IN MEZAGITAMAB

• XOMA ROYALTY CORP - RETAINS LOW ROYALTY AND $13 MILLION IN MILESTONES FOR MEZAGITAMAB

• XOMA ROYALTY: ENTITLED TO PAYMENTS ASSOCIATED WITH NINE DEVELOPMENT-STAGE ASSETS HELD WITHIN TAKEDA'S EXTERNALIZED ASSETS PORTFOLIO